title: Tuberculosis After Kidney Transplant in the Samara Region of Russia: Possible Solutions to Diagnosis and Treatment.
abstract: Infections are the most important of all fatal complications in the first year after kidney transplant. They often differ in the severity of their course and can manifest in atypical symptoms. Further, their complex presentation significantly impedes diagnosis and treatment selection. Tuberculosis is unique among infections that affect patients posttransplant because it is accompanied by significant difficulties in detection, treatment, and prevention. The clinical application of a decision support system that can predict the likelihood (percentage) of patients developing posttransplant tuberculosis appears promising.
authors.affiliation: Samara State Medical University, Samara, Russian Federation.
authors.forename: Boris I
authors.initials: BI
authors.lastname: Yaremin
authors.forename: Anna A
authors.initials: AA
authors.lastname: Starostina
authors.forename: Igor L
authors.initials: IL
authors.lastname: Tsygankov
mesh_terms: D000293:Adolescent; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D020000:Decision Support Systems, Clinical; D003661:Decision Support Techniques; D004359:Drug Therapy, Combination; D005260:Female; D006085:Graft Survival; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D017010:Reminder Systems; D018570:Risk Assessment; D012307:Risk Factors; D012426:Russia; D013997:Time Factors; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology* / Q000401:mortality; D055815:Young Adult
chemical_list: D000995:Antitubercular Agents; D007166:Immunosuppressive Agents